Recombinant Staphylococcus aureus Molybdenum cofactor biosynthesis protein B (moaB)

Shipped with Ice Packs
In Stock

Product Specs

Form
Lyophilized powder. We will ship the in-stock format by default. If you have specific format requirements, please note them when ordering.
Lead Time
Delivery times vary by purchase method and location. Consult your local distributor for specifics. All proteins ship with blue ice packs by default. Contact us in advance for dry ice shipping (extra fees apply).
Notes
Avoid repeated freeze-thaw cycles. Working aliquots are stable at 4°C for up to one week.
Reconstitution
Briefly centrifuge the vial before opening. Reconstitute in sterile deionized water to 0.1-1.0 mg/mL. Add 5-50% glycerol (final concentration) and aliquot for long-term storage at -20°C/-80°C. Our default final glycerol concentration is 50%.
Shelf Life
Shelf life depends on storage conditions, buffer components, storage temperature, and protein stability. Liquid form is generally stable for 6 months at -20°C/-80°C. Lyophilized form is generally stable for 12 months at -20°C/-80°C.
Storage Condition
Store at -20°C/-80°C upon receipt. Aliquot for multiple uses. Avoid repeated freeze-thaw cycles.
Tag Info
The tag type is determined during manufacturing. If you require a specific tag, please inform us and we will prioritize its development.
Synonyms
moaB; SA2070; Molybdenum cofactor biosynthesis protein B
Buffer Before Lyophilization
Tris/PBS-based buffer, 6% Trehalose.
Datasheet
Please contact us to get it.
Expression Region
1-168
Protein Length
full length protein
Purity
>85% (SDS-PAGE)
Species
Staphylococcus aureus (strain N315)
Target Names
moaB
Target Protein Sequence
MGEHQNVKLN RTVKAAVLTV SDTRDFVTDK GGQCVRQLLQ ADDVEVSDAH YTIVKDEKVA ITTQVKKWLE EDIDVIITTG GTGIAQRDVT IEAVKPLLTK EIEGFGELFR YLSYVEDVGT RALLSRAVAG TVNNKLIFSI PGSTGAVKLA LEKLIKPELN HLIHELTK
Uniprot No.

Target Background

Function
May be involved in molybdopterin biosynthesis.
Database Links

KEGG: sau:SA2070

Protein Families
MoaB/Mog family

Q&A

What is the molybdenum cofactor biosynthesis pathway in Staphylococcus aureus?

The molybdenum cofactor (Moco) biosynthesis pathway in S. aureus is essential for producing functional molybdoenzymes that participate in various metabolic processes. Similar to the pathway identified in humans, bacterial Moco biosynthesis typically involves multiple steps including the formation of a precursor molecule, sulfur transfer, and final maturation steps. In humans, the MOCS3 protein contains domains similar to bacterial MoeB proteins and plays a crucial role in adenylation and thiocarboxylation during Moco biosynthesis . The S. aureus pathway likely involves analogous proteins, with moaB functioning as a key component in the early biosynthetic steps of Moco formation.

How does moaB protein structurally compare to other molybdenum cofactor biosynthesis proteins?

The moaB protein in S. aureus shares structural similarities with molybdenum cofactor biosynthesis proteins in other organisms. Based on comparative studies of molybdenum cofactor biosynthesis proteins, moaB likely belongs to a family of proteins containing nucleotide-binding domains. The human MOCS3 protein, for example, contains an N-terminal domain similar to E. coli MoeB and a C-terminal rhodanese-like domain that participates in sulfur transfer reactions . While specific structural data for S. aureus moaB is not extensively documented, bioinformatic analyses suggest it contains conserved motifs typical of proteins involved in the early steps of Moco biosynthesis.

What experimental approaches are used to confirm moaB function in S. aureus?

To confirm moaB function in S. aureus, researchers employ multiple complementary approaches:

  • Gene knockout studies: Creating moaB deletion mutants to observe phenotypic changes

  • Complementation assays: Restoring function by introducing recombinant moaB into knockout strains

  • Activity assays: Measuring enzymatic activities associated with molybdoenzymes

  • Expression analysis: Determining moaB expression under different growth conditions

  • Protein-protein interaction studies: Identifying binding partners in the Moco biosynthesis pathway

These approaches follow standard experimental design principles including appropriate controls, variable isolation, and systematic hypothesis testing . When evaluating functional changes, researchers typically measure activity of molybdoenzymes as downstream indicators of Moco biosynthesis disruption.

What expression systems are optimal for producing recombinant S. aureus moaB?

The optimal expression system for recombinant S. aureus moaB depends on research objectives and desired protein characteristics. The following table compares commonly used expression systems:

Expression SystemAdvantagesLimitationsBest For
E. coli BL21(DE3)High yield, rapid growth, economicalPotential improper folding, inclusion body formationStructural studies, antibody production
E. coli RosettaAccommodates rare codons found in S. aureusModerate yieldPreserving native protein structure
Bacillus subtilisGram-positive system closer to native environmentLower yields than E. coliFunctional studies requiring proper folding
Cell-free systemsAvoids toxicity issues, rapidExpensive, lower yieldProteins toxic to host cells

For functional studies, gene expression is typically driven by IPTG-inducible promoters (T7, tac) with optimization of temperature (typically 16-25°C for better folding) and induction parameters. The protein is commonly expressed with an N-terminal His6-tag to facilitate purification while minimizing interference with function .

What purification strategies yield the highest purity and activity of recombinant moaB?

A multi-step purification protocol typically yields the highest purity and activity for recombinant S. aureus moaB:

  • Initial capture: Immobilized metal affinity chromatography (IMAC) using Ni-NTA resin for His-tagged moaB

  • Intermediate purification: Ion exchange chromatography to separate based on charge properties

  • Polishing step: Size exclusion chromatography to obtain homogeneous protein and remove aggregates

  • Buffer optimization: Final buffer composition (typically 20-50 mM Tris or phosphate, pH 7.5-8.0, 100-300 mM NaCl, 1-5 mM DTT) to maintain stability and activity

Buffer conditions should be carefully optimized as modifications at the N-terminus (such as gluconoylation observed with His-tagged proteins) can create heterogeneity that may affect stability but not necessarily function, as observed with the MOCS3 rhodanese-like domain .

How can researchers confirm proper folding and activity of recombinant moaB?

Confirming proper folding and activity of recombinant moaB involves multiple analytical techniques:

  • Circular dichroism (CD) spectroscopy: Assesses secondary structure elements and proper folding

  • Thermal shift assays: Evaluates protein stability and identifies stabilizing buffer conditions

  • Size exclusion chromatography with multi-angle light scattering (SEC-MALS): Confirms protein homogeneity and oligomeric state

  • Enzymatic activity assays: Measures adenylation activities using colorimetric assays or radiolabeled substrates

  • Mass spectrometry: Confirms protein integrity and identifies post-translational modifications

For activity confirmation, researchers can use in vitro reconstitution systems similar to those developed for human MOCS3, which measure the ability to catalyze specific reactions in the Moco biosynthesis pathway .

What are the key catalytic residues in S. aureus moaB and how can they be studied?

The key catalytic residues in S. aureus moaB can be identified and studied through a combination of approaches:

  • Sequence alignment: Comparing S. aureus moaB with homologous proteins from other organisms where catalytic residues have been characterized

  • Homology modeling: Creating structural models based on solved structures of homologous proteins

  • Site-directed mutagenesis: Systematically replacing conserved residues to assess functional impact

  • Enzyme kinetics: Measuring activity changes of mutant proteins compared to wild-type

For the related rhodanese-like domains involved in Moco biosynthesis in humans, conserved cysteine residues in the active site loop (such as C412 in human MOCS3-RLD) are critical for persulfide formation and sulfur transfer reactions . Similar approaches can identify the catalytic machinery in S. aureus moaB.

How does the structure of moaB influence its interaction with other Moco biosynthesis proteins?

The structural features of moaB influence its interactions with other Moco biosynthesis proteins through:

  • Surface electrostatics: Charged patches that facilitate protein-protein recognition

  • Binding pockets: Conserved regions that accommodate substrate molecules

  • Flexible loops: Dynamic regions that undergo conformational changes during catalysis

  • Interface residues: Specific amino acids that form contacts with partner proteins

These interactions can be studied using techniques such as:

  • Yeast two-hybrid assays: Identifies interaction partners in vivo

  • Pull-down assays: Confirms direct physical interactions

  • Surface plasmon resonance (SPR): Measures binding kinetics and affinities

  • Isothermal titration calorimetry (ITC): Determines thermodynamic parameters of binding

  • Crosslinking coupled with mass spectrometry: Identifies specific interaction interfaces

How does moaB function contribute to S. aureus virulence and adaptation?

The contribution of moaB to S. aureus virulence and adaptation likely stems from its role in producing functional molybdoenzymes that may:

  • Support metabolic flexibility: Enable growth under varied nutrient conditions encountered during infection

  • Contribute to stress resistance: Help bacteria cope with oxidative stress generated by host immune responses

  • Facilitate adaptation: Support bacterial survival in different host environments

S. aureus is known for its adaptability and extensive virulence factors that enable it to evade host immune responses . The bacterium produces numerous virulence and immune evasion factors that hinder human immune responses, particularly neutrophil function . While the specific contribution of moaB to these processes is not directly documented in the provided references, molybdoenzymes generally play roles in bacterial adaptation to changing environments, which could be significant during infection.

What experimental models are most appropriate for studying moaB's role in S. aureus pathogenesis?

Several experimental models can be employed to study moaB's role in S. aureus pathogenesis:

Model SystemApplicationsAdvantagesLimitations
Cell culture (macrophages)Host-pathogen interactionsControlled conditions, human relevanceLimited complexity
Zebrafish infectionIn vivo pathogenesisVisualizable, vertebrate immune systemEvolutionary distance from humans
Mouse infection modelsSystemic and localized infectionsMammalian physiology, well-characterizedEthical considerations, cost
Experimental evolution in macrophagesAdaptation mechanismsReveals selective pressuresMay not reflect in vivo complexity

For studying S. aureus interactions with host immune cells, macrophage infection models have proven valuable, as they allow observation of bacterial adaptations under immune pressure . Zebrafish infection models can also be useful for in vivo studies, though they may reveal different fitness costs for bacterial adaptations compared to in vitro systems .

How can gene knockout and complementation strategies be optimized for studying moaB function?

Optimizing gene knockout and complementation strategies for studying moaB function requires careful experimental design:

  • Precise gene targeting: Using CRISPR-Cas9 or homologous recombination approaches for clean deletions without polar effects

  • Complementation controls:

    • Expressing wild-type moaB from a neutral chromosomal locus under native promoter control

    • Using inducible promoters to titrate expression levels

    • Including epitope tags that don't interfere with function for protein detection

  • Phenotypic analyses:

    • Growth curves under different conditions (aerobic, anaerobic, nutrient-limited)

    • Survival in host-relevant conditions (oxidative stress, neutrophil killing assays)

    • Enzyme activity assays for molybdoenzymes

  • Experimental controls:

    • Empty vector controls for complementation studies

    • Wild-type strain controls alongside mutants

    • Complementation with catalytically inactive versions to distinguish structural from enzymatic roles

When designing these experiments, researchers should follow systematic experimental design principles, clearly defining independent variables (genetic manipulations) and dependent variables (phenotypic outcomes) .

What mass spectrometry approaches can identify post-translational modifications in recombinant moaB?

Mass spectrometry (MS) approaches for identifying post-translational modifications (PTMs) in recombinant moaB include:

  • Bottom-up proteomics: Protein digestion followed by liquid chromatography-tandem mass spectrometry (LC-MS/MS)

    • Enables identification of specific modified residues

    • Allows quantification of modification stoichiometry

  • Intact protein MS (top-down approach):

    • Provides information on combinations of modifications

    • Determines heterogeneity in protein populations

  • Targeted MS approaches:

    • Selected/multiple reaction monitoring (SRM/MRM) for specific modifications

    • Parallel reaction monitoring (PRM) for improved specificity

These approaches have successfully identified PTMs in related proteins, such as the persulfide group formation on the conserved cysteine residue (C412) in the human MOCS3 rhodanese-like domain and gluconoylation at the N-terminus of His-tagged proteins . Similar modifications might occur in recombinant S. aureus moaB and could impact its function or stability.

How can researchers design experiments to resolve contradictory findings about moaB function?

When faced with contradictory findings about moaB function, researchers should implement the following experimental design strategies:

  • Systematic variable isolation:

    • Test one variable at a time while controlling others

    • Use factorial designs to evaluate interaction effects

    • Implement appropriate controls for each experimental condition

  • Method triangulation:

    • Apply multiple independent techniques to address the same question

    • Compare in vitro biochemical results with in vivo genetic approaches

    • Combine structural, functional, and computational methods

  • Reproducibility enhancements:

    • Standardize protocols across laboratories

    • Use multiple bacterial strains to account for strain-specific effects

    • Implement blinded analysis where applicable

  • Confounding variable identification:

    • Evaluate growth conditions that might affect results

    • Consider protein expression levels and tagging effects

    • Assess the impact of media composition on molybdenum availability

  • Statistical rigor:

    • Use appropriate statistical tests with adequate sample sizes

    • Report effect sizes alongside p-values

    • Consider meta-analysis of multiple studies

What crystallization strategies are most successful for obtaining diffraction-quality moaB crystals?

Obtaining diffraction-quality crystals of recombinant S. aureus moaB may require multiple approaches:

Crystallization StrategyKey ParametersAdvantagesConsiderations
Sparse matrix screeningCommercial screens, varied precipitantsBroad condition samplingRequires optimization
Seeding techniquesMicroseed matrix screeningImproves crystal qualityNeeds initial crystals
Surface entropy reductionMutation of flexible residuesPromotes crystal contactsMay affect function
Co-crystallizationAddition of substrates/cofactorsStabilizes functional conformationsRequires pure ligands
Truncation constructsRemove flexible regionsImproves crystallizabilityMay remove functional domains

Optimization strategies include:

  • Fine-tuning precipitant concentration and pH

  • Adjusting protein concentration (typically 5-15 mg/mL)

  • Incorporating additives that stabilize the protein

  • Screening different temperatures (4°C, 16°C, 20°C)

  • Using oil barriers for controlled vapor diffusion rates

For challenging proteins, alternative approaches like lipidic cubic phase (for membrane-associated forms) or crystallization chaperones may be necessary.

What computational approaches can predict moaB interaction networks in S. aureus?

Multiple computational approaches can predict moaB interaction networks in S. aureus:

  • Sequence-based methods:

    • Co-evolutionary analysis to identify correlated mutations

    • Genomic context analysis (gene neighborhood, gene fusion, phylogenetic profiling)

    • Primary sequence-based interaction prediction

  • Structure-based methods:

    • Protein-protein docking simulations

    • Interface prediction based on surface properties

    • Molecular dynamics simulations to identify conformational changes

  • Network-based methods:

    • Guilt-by-association approaches in functional networks

    • Pathway enrichment analysis

    • Network topology analysis to identify hub proteins

  • Data integration approaches:

    • Bayesian integration of multiple evidence types

    • Machine learning models trained on known interactions

    • Knowledge-based methods incorporating literature mining

These predictions can generate testable hypotheses about moaB's functional partners in the molybdenum cofactor biosynthesis pathway and potentially identify unexpected interactions with virulence-related proteins in S. aureus.

How can evolutionary analysis of moaB sequences inform experimental approaches?

Evolutionary analysis of moaB sequences can significantly inform experimental approaches through:

  • Conservation mapping:

    • Identification of highly conserved residues likely essential for function

    • Mapping conservation patterns onto structural models to prioritize residues for mutagenesis

    • Recognition of species-specific variations that might relate to niche adaptation

  • Selection pressure analysis:

    • Detection of residues under positive selection that may confer adaptive advantages

    • Identification of regions under strong purifying selection indicating functional constraints

    • Recognition of coevolving residue networks suggesting functional coupling

  • Phylogenetic profiling:

    • Correlation of moaB presence/absence with specific bacterial traits

    • Identification of lineage-specific adaptations in S. aureus compared to other species

    • Detection of horizontal gene transfer events that might affect function

  • Ancestral sequence reconstruction:

    • Testing hypotheses about evolutionary trajectories of enzyme function

    • Evaluating the functional impact of historical mutations

These evolutionary insights can guide the design of site-directed mutagenesis experiments to test hypotheses about structure-function relationships and adaptation mechanisms specific to S. aureus.

How does moaB expression change during different stages of S. aureus infection?

While specific data on moaB expression changes during S. aureus infection is not directly available from the search results, similar studies of S. aureus gene expression during infection suggest methodologies to investigate this question:

  • Transcriptomic approaches:

    • RNA-seq analysis of bacteria recovered from different infection sites

    • qRT-PCR validation of expression changes

    • Single-cell RNA-seq to capture population heterogeneity

  • Reporter systems:

    • Promoter-GFP fusions to monitor expression in real-time

    • Dual-reporter systems to normalize for bacterial numbers

    • Inducible systems to manipulate expression timing

  • In vivo expression technologies:

    • IVET or similar approaches to identify in vivo induced genes

    • Tn-seq to determine conditional essentiality

S. aureus is known to undergo adaptive changes during infection, including the development of small colony variants (SCVs) with altered metabolic profiles that promote survival in host environments . Studying moaB expression in these contexts could reveal its role in adaptation to host pressures.

What animal models are most suitable for studying the impact of moaB mutations on S. aureus virulence?

Several animal models can be used to study the impact of moaB mutations on S. aureus virulence, each with specific advantages:

Animal ModelInfection TypeMeasurementsAdvantagesLimitations
Mouse systemicIntravenousBacterial burden, survival, organ pathologyWell-established, multiple readoutsRequires large numbers for survival studies
Mouse skin/soft tissueSubcutaneousAbscess size, bacterial clearanceMimics common S. aureus infectionsVariable response
Zebrafish embryoMicroinjectionReal-time visualization, survivalTransparent, innate immunity focusEvolutionary distance from mammals
Rabbit endocarditisCardiac catheter + IVVegetation formation, bacterial burdenClinically relevantTechnical complexity, cost
Rat pneumoniaIntratrachealLung pathology, bacterial clearanceModels respiratory infectionTechnical difficulty

Zebrafish models have been successfully used to study S. aureus small colony variants and can reveal differences in virulence and fitness costs of bacterial adaptations, as demonstrated in experimental evolution studies . The choice of model should align with the specific aspects of S. aureus pathogenesis being investigated.

How can in vitro evolution experiments inform our understanding of moaB's role in S. aureus adaptation?

In vitro evolution experiments can provide valuable insights into moaB's role in S. aureus adaptation:

  • Experimental design approaches:

    • Serial passage in selective conditions (nutrient limitation, host-mimicking environments)

    • Co-culture with host cells (macrophages, neutrophils) to impose immune selection

    • Fluctuating environments to study adaptive flexibility

  • Analysis methods:

    • Whole-genome sequencing to identify adaptive mutations

    • Transcriptomic profiling to detect expression changes

    • Comparative phenotypic analysis between evolved and ancestral strains

  • Validation approaches:

    • Reconstruction of identified mutations in wild-type background

    • Competition assays to measure fitness effects

    • Functional assays to determine mechanistic impacts

Quick Inquiry

Personal Email Detected
Please use an institutional or corporate email address for inquiries. Personal email accounts ( such as Gmail, Yahoo, and Outlook) are not accepted. *
© Copyright 2025 TheBiotek. All Rights Reserved.